down arrow

Creative Medical Technology Holdings, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US22529Y4089
USD
2.22
0.01 (0.23%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

2.082.40

52 Week

1.696.90
Valuation
Technical
Day's Volume

CASH

234.29 k

Shareholding (Mar 2025)

FII

0.69%

Held by 4 FIIs

DII

97.26%

Held by 2 DIIs

Promoter

0.00%

How big is Creative Medical Technology Holdings, Inc.?

22-Jun-2025

As of Jun 18, Creative Medical Technology Holdings, Inc. has a market capitalization of 5.79 million and reported net sales of 0.01 million with a net profit of -6.09 million for the latest four quarters ending in March 2025. Shareholder's funds were 6.34 million, with total assets of 6.67 million as of December 2024.

Market Cap: As of Jun 18, Creative Medical Technology Holdings, Inc. has a market capitalization of 5.79 million, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters ending in March 2025, the company reported net sales of 0.01 million and a net profit of -6.09 million.<BR><BR>Balance Sheet Snapshot: As of December 2024, the shareholder's funds amounted to 6.34 million, while total assets were reported at 6.67 million.

Read More

What does Creative Medical Technology Holdings, Inc. do?

22-Jun-2025

Creative Medical Technology Holdings, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $2 million as of March 2025. The company has a market cap of $5.79 million and key metrics indicate it is currently loss-making with a negative return on equity.

Overview: <BR>Creative Medical Technology Holdings, Inc. operates within the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 5.79 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.96 <BR>Return on Equity: -75.55% <BR>Price to Book: 0.72<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is Creative Medical Technology Holdings, Inc. technically bullish or bearish?

20-Sep-2025

As of August 28, 2025, Creative Medical Technology Holdings, Inc. has shifted to a bullish trend, supported by positive indicators across multiple timeframes, while year-to-date it has returned 51.95%, outperforming the S&P 500's 12.22%, though it has underperformed over three years with a return of -48.41% compared to the S&P 500's 70.41%.

As of 28 August 2025, the technical trend for Creative Medical Technology Holdings, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and a bullish daily moving average. The KST is bullish weekly and mildly bullish monthly, while the OBV is bullish on both timeframes. The RSI shows no signals on both weekly and monthly timeframes.<BR><BR>In terms of performance, the stock has returned 51.95% year-to-date, significantly outperforming the S&P 500's 12.22% return in the same period. However, over longer periods, the stock has underperformed the benchmark, with a 3-year return of -48.41% compared to the S&P 500's 70.41%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 9 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.96

stock-summary
Return on Equity

-84.45%

stock-summary
Price to Book

1.25

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-33.43%
0%
-33.43%
6 Months
-3.06%
0%
-3.06%
1 Year
-9.39%
0%
-9.39%
2 Years
-51.42%
0%
-51.42%
3 Years
431.61%
0%
431.61%
4 Years
-89.95%
0%
-89.95%
5 Years
-76.63%
0%
-76.63%

Creative Medical Technology Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Creative Medical Technology Holdings, Inc. technically bullish or bearish?

As of 28 August 2025, the technical trend for Creative Medical Technology Holdings, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and a bullish daily moving average. The KST is bullish weekly and mildly bullish monthly, while the OBV is bullish on both timeframes. The RSI shows no signals on both weekly and monthly timeframes. In terms of performance, the stock has returned 51.95% year-to-date, significantly outperforming the S&P 500's 12.22% return in the same period. However, over longer periods, the stock has underperformed the benchmark, with a 3-year return of -48.41% compared to the S&P 500's 70.41%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-2.30%
EBIT Growth (5y)
-225.78%
EBIT to Interest (avg)
-4.59
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.96
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.02%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.77
EV to EBIT
0.24
EV to EBITDA
0.25
EV to Capital Employed
-1.51
EV to Sales
-1.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-75.55%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (2.05%)

Foreign Institutions

Held by 4 Foreign Institutions (0.69%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 25.00% vs -45.45% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.20",
          "val2": "-1.60",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.20",
          "val2": "-1.60",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-203,163.30%",
          "chgp": "20,316.33%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.77% vs 47.52% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.60",
          "val2": "-5.50",
          "chgp": "-1.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.50",
          "val2": "-5.30",
          "chgp": "-3.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-522,169.20%",
          "val2": "-624,459.10%",
          "chgp": "10,228.99%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.20
-1.60
25.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.20
-1.60
25.00%
Operating Profit Margin (Excl OI)
0.00%
-203,163.30%
20,316.33%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 25.00% vs -45.45% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-5.60
-5.50
-1.82%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.50
-5.30
-3.77%
Operating Profit Margin (Excl OI)
-522,169.20%
-624,459.10%
10,228.99%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -3.77% vs 47.52% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Creative Medical Technology Holdings, Inc. stock-summary
stock-summary
Creative Medical Technology Holdings, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."